Stock PCR PCC ROKITA SA
Add to a list
To use this feature you must be a member
Log inSign up

Financials PCC Rokita SA

Equities

PCR

PLPCCRK00076

Specialty Chemicals

Delayed Warsaw S.E.
Other stock markets
 03:13:04 2024-04-30 am EDT 		5-day change 1st Jan Change
101 PLN -1.17% Intraday chart for PCC Rokita SA -0.98% +5.32%
Mar. 20 PCC Rokita SA Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 PCC Rokita SA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2023 2024 2025 2026
Capitalization 1 970.8 1,028 1,819 1,904 2,029 - -
Enterprise Value (EV) 1 1,719 1,663 1,819 2,213 2,562 2,501 2,640
P/E ratio 10.4 x - 4.36 x 7.11 x 41.9 x 12.4 x -
Yield 6.97% 7.08% - 22.5% 3.67% 5.14% -
Capitalization / Revenue 0.65 x 0.7 x - 0.8 x 0.87 x 0.8 x 0.83 x
EV / Revenue 1.15 x 1.13 x - 0.93 x 1.1 x 0.98 x 1.08 x
EV / EBITDA 5.94 x 5.01 x - 4.27 x 8.77 x 5.45 x 5.79 x
EV / FCF 22.4 x 8.51 x - 7.48 x 94.4 x 17.3 x 15.2 x
FCF Yield 4.47% 11.7% - 13.4% 1.06% 5.78% 6.59%
Price to Book - 1.31 x - - - - -
Nbr of stocks (in thousands) 19,853 19,853 19,853 19,853 19,853 - -
Reference price 2 48.90 51.80 91.60 95.90 102.2 102.2 102.2
Announcement Date 3/19/20 3/16/21 3/16/22 3/20/24 - - -
1PLN in Million2PLN
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2023 2024 2025 2026
Net sales 1 1,492 1,476 - 2,388 2,334 2,547 2,441
EBITDA 1 289.7 332.1 - 518.6 292 459 456
EBIT 1 173.6 179.7 - 342.9 92 253.7 243
Operating Margin 11.64% 12.17% - 14.36% 3.94% 9.96% 9.95%
Earnings before Tax (EBT) 1 - - - 315.5 58 197 209
Net income 1 93.26 117.4 417.3 267.8 48 179.4 174
Net margin 6.25% 7.96% - 11.22% 2.06% 7.04% 7.13%
EPS 2 4.700 - 21.02 13.49 2.440 8.230 -
Free Cash Flow 1 76.88 195.4 - 295.8 27.15 144.6 174
FCF margin 5.15% 13.24% - 12.38% 1.16% 5.67% 7.13%
FCF Conversion (EBITDA) 26.54% 58.82% - 57.04% 9.3% 31.49% 38.16%
FCF Conversion (Net income) 82.43% 166.39% - 110.43% 56.56% 80.57% 100%
Dividend per Share 2 3.410 3.670 - 21.57 3.750 5.250 -
Announcement Date 3/19/20 3/16/21 3/16/22 3/20/24 - - -
1PLN in Million2PLN
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2023 2024 2025 2026
Net Debt 1 749 635 - 309 533 472 611
Net Cash position 1 - - - - - - -
Leverage (Debt/EBITDA) 2.584 x 1.911 x - 0.5954 x 1.825 x 1.028 x 1.339 x
Free Cash Flow 1 76.9 195 - 296 27.2 145 174
ROE (net income / shareholders' equity) - - - 19.4% 3.8% 13% 13.7%
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share - 39.60 - - - - -
Cash Flow per Share - - - - - - -
Capex 1 - 170 - 216 228 228 250
Capex / Sales - 11.53% - 9.06% 9.75% 8.93% 10.24%
Announcement Date 3/19/20 3/16/21 3/16/22 3/20/24 - - -
1PLN in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for PCC Rokita SA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
102.2 PLN
Average target price
100.4 PLN
Spread / Average Target
-1.76%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

1st Jan change Capi.
PCC ROKITA SA Stock PCC Rokita SA
+5.32% 504M
ECOLAB INC. Stock Ecolab Inc.
+11.76% 63.38B
SIKA AG Stock Sika AG
-3.47% 46.51B
GIVAUDAN SA Stock Givaudan SA
+13.55% 39.91B
FUJIFILM HOLDINGS CORPORATION Stock Fujifilm Holdings Corporation
+19.57% 25.57B
EMS-CHEMIE HOLDING AG Stock EMS-CHEMIE HOLDING AG
+8.96% 18.95B
CELANESE CORPORATION Stock Celanese Corporation
+1.44% 17.58B
POSCO FUTURE M CO., LTD. Stock Posco Future M Co., Ltd.
-20.33% 16.1B
SYMRISE AG Stock Symrise AG
+1.36% 14.98B
ALBEMARLE CORPORATION Stock Albemarle Corporation
-12.98% 14.78B
Other Specialty Chemicals
  1. Stock Market
  2. Equities
  3. PCR Stock
  4. Financials PCC Rokita SA